Why the study?
Although chronic dialysis improves survival in end-stage renal disease, annual mortality remains approximately 20% and quality of life is substantially reduced, prompting evaluation of the correlation between residual renal function and hypertension.
Does the presence of residual renal function correlate with the prevalence and control of hypertension in patients with ESRD on regular haemodialysis?
Does the presence of residual renal function correlate with the prevalence and control of hypertension in patients with ESRD on regular haemodialysis?
In patients on regular hemodialysis, the presence of residual renal function is associated with a lower prevalence of hypertension and lower interdialytic weight gain, though it does not significantly alter the number of medications needed for blood pressure control.
Answers are grounded in this paper and cite their sources.
Observed correlation between residual renal function and hypertension in hemodialysis; leaves open causal impact and need for prospective trials.
Objective: To evaluate the correlation between residual renal function and hypertension in regular haemodialysis patients. Background: Initiating chronic dialysis treatment gives end-stage renal disease patients a new lease on life. However, the annual mortality rate in dialysis patients is ~20% and quality of life is substantially reduced. Patients and Methods: This study was carried out on a reasonable number of subjects on regular haemodialysis divided into two groups. All were given informed consent and, the study was approved by the ethics committee of Menoufia University. Results: There was significant relation between presence of residual renal function and hypertension in patients with ESRD on regular haemodialysis, but the relation between residual renal function and control of hypertension is not statistically significant. 40% of group 1 were hypertensive, 66.7% of group 2 patients were hypertensive, the interdialytic weight gain mean was 1.42 in group 1 and 2.37 in group 2. Control of hypertension was achieved in 63.6% of group 1 patients by one drug, 27.3% patients by 2 drugs; however 9.1% of patients need 3 drugs to control their blood pressure, while in group 2 40% of patients were controlled by one drug, 45% with 2 drugs and 15% need 3 drugs to control blood pressure. Conclusion: There is significant relation between presence of residual renal function and hypertension in patients with ESRD on regular haemodialysis, but the relation between residual renal function and control of hypertension is not statistically significant.
No takes yet. Share an insight, caveat, or question.
Khamis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: